title: Prostate cancer: Intermediate efficacy end points to assess modern therapies.
authors.affiliation: Laboratory of Tumor Immunology and Biology, Center for Cancer Research, National Cancer Institute, 10 Center Drive, Room 8B09, Bethesda, MD 20892, USA.
authors.forename: Ravi A
authors.initials: RA
authors.lastname: Madan
authors.forename: James L
authors.initials: JL
authors.lastname: Gulley
mesh_terms: D000728:Androgens / Q000378:metabolism*; D023381:Endpoint Determination; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000235:genetics*; D011471:Prostatic Neoplasms / Q000188:drug therapy*
chemical_list: D000728:Androgens